Magnetised molecules used to monitor breast cancer

For Cambridge students For our researchers Business and enterprise Colleges and Departments Email and phone search Give to Cambridge Museums and collections Undergraduate - Events and open days Fees and finance Postgraduate - Postgraduate courses Fees and funding Frequently asked questions International students Continuing education Executive and professional education Courses in education How the University and Colleges work Visiting the University Equality and diversity A global university Public engagement Give to Cambridge - A new type of scan that involves magnetising molecules allows doctors to see in real-time which regions of a breast tumour are active, according to research at the University of Cambridge and published in Proceedings of the National Academy of Sciences . This is one of the most detailed pictures of the metabolism of a patient's breast cancer that we've ever been able to achieve. It's like we can see the tumour 'breathing' Kevin Brindle This is the first time researchers have demonstrated that this scanning technique, called carbon-13 hyperpolarised imaging, can be used to monitor breast cancer. The team based at the Cancer Research UK Cambridge Institute and the Department of Radiology, University of Cambridge, tested the technique in seven patients with various types and grades of breast cancer before they had received any treatment. They used the scan to measure how fast the patients' tumours were metabolising a naturally occurring molecule called pyruvate, and were able to detect differences in the size, type and grade of tumours - a measure of how fast growing, or aggressive the cancer is.